Schizophrenia adherence therapy improves symptoms, not adherence

From Clinical Psychiatry News, 23 April 2013: Adherence therapy improves symptoms in patients with schizophrenia but does not appear to affect adherence, treatment attitudes. or functioning, according to results of a randomized controlled trial. “We observed a small effect of AT [adherence therapy] on patient symptoms but not adherence, treatment attitudes, or functioning following an … Continue reading Schizophrenia adherence therapy improves symptoms, not adherence

Continued engagement with schizophrenia patients can prevent declines

From Clinical Psychiatry News, 23 April 2013: A review of the causes and impact of hospitalization in schizophrenia has shown that hospitalization is more likely the result of cognitive and functional decline rather than a contributor. “While it is difficult to disentangle the consequence of the reasons for hospitalization from the effects of hospitalization, most … Continue reading Continued engagement with schizophrenia patients can prevent declines

Neuroimaging reveals characteristics of deficit schizophrenia

From Clinical Psychiatry News, 19 March 2013: The deficit subtype of schizophrenia is characterized by white matter tract disruption, while all subtypes of schizophrenia feature a reduction in cortical thickness, a cross-sectional neuroimaging study has found. Patients with deficit schizophrenia showed significant disruption of white matter at the right inferior longitudinal fasciculus, the right arcuate … Continue reading Neuroimaging reveals characteristics of deficit schizophrenia

Genotype plays role in schizophrenia response to folate

From Clinical Psychiatry News, 19 March 2013: Folate and vitamin B12 supplements may improve the negative symptoms of schizophrenia but only in patients with a genetic variant that influences folate metabolism, a study has shown. “Although four such variants have previously been associated with negative symptom severity, the genotype that contributed most strongly to treatment … Continue reading Genotype plays role in schizophrenia response to folate